tiprankstipranks
Biosergen AB (SE:BIOSGN)
:BIOSGN
Sweden Market
BIOSGN
Biosergen AB
RESEARCH TOOLSreports
Want to see SE:BIOSGN full AI Analyst Report?

Biosergen AB (BIOSGN) Financial Statements

0 Followers

Biosergen AB Financial Overview

Biosergen AB's market cap is currently kr14.68M. The company's EPS TTM is kr-17.38; its P/E ratio is -0.36; Biosergen AB is scheduled to report earnings on June 9, 2026, and the estimated EPS forecast is kr―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenuekr 0.00kr 0.00kr 0.00kr 0.00kr 8.57M
Gross Profitkr 0.00kr 0.00kr -456.00Kkr -280.00Kkr -213.60K
Operating Incomekr -41.39Mkr -20.69Mkr -27.27Mkr -34.13Mkr -33.71M
EBITDAkr -40.84Mkr -19.20Mkr 228.00Kkr -34.05Mkr -34.32M
Net Incomekr -40.82Mkr -19.20Mkr -27.04Mkr -34.05Mkr -34.32M
Balance Sheet
Cash & Short-Term Investmentskr 15.37Mkr 50.61Mkr 1.88Mkr 29.34Mkr 21.66M
Total Assetskr 19.83Mkr 52.85Mkr 7.20Mkr 33.79Mkr 29.49M
Total Debtkr 0.00kr 0.00kr 0.00kr 0.00kr 0.00
Net Debtkr -15.37Mkr -50.61Mkr -1.88Mkr -29.34Mkr -21.66M
Total Liabilitieskr 8.06Mkr 3.71Mkr 5.08Mkr 11.00Mkr 9.25M
Stockholders' Equitykr 11.76Mkr 48.21Mkr 2.12Mkr 22.79Mkr 20.23M
Cash Flow
Free Cash Flowkr -36.81Mkr -16.63Mkr -32.60Mkr -29.44Mkr -37.75M
Operating Cash Flowkr -36.81Mkr -16.63Mkr -32.60Mkr -29.44Mkr -37.75M
Investing Cash Flowkr 0.00kr 0.00kr 0.00kr 0.00kr 0.00
Financing Cash Flowkr -38.00Kkr 65.36Mkr 5.14Mkr 37.12Mkr 58.83M
Currency in SEK

Biosergen AB Earnings and Revenue History

Income Statement >

Biosergen AB Debt to Assets

Balance Sheet >

Biosergen AB Cash Flow

Cash Flow >

Biosergen AB Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
Earnings >